Page last updated: 2024-10-27

gliclazide and Insulinoma

gliclazide has been researched along with Insulinoma in 4 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Insulinoma: A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.

Research Excerpts

Excerpt	Relevance	Reference
"A 74-year-old woman with type 2 diabetes mellitus who had been treated with a sulfonylurea for 6 years began experiencing frequent episodes of hypoglycemia."	1.34	Insulinoma causing hypoglycemia in a patient with type 2 diabetes. ( Chang, WH; Chen, TL; Lei, WY; Wang, CY; Wang, TE; Yang, TL, 2007)

4 other studies available for gliclazide and Insulinoma

Article	Year
Activation of KATP channels by H2S in rat insulin-secreting cells and the underlying mechanisms. The Journal of physiology, 2005, Dec-01, Volume: 569, Issue:Pt 2 Topics: Adenosine Triphosphate; Animals; Blotting, Western; Cell Line, Tumor; Cystathionine gamma-Lyase; Dia	2005
Effect of gliclazide on DNA damage in human peripheral blood lymphocytes and insulinoma mouse cells. Chemico-biological interactions, 2006, Sep-25, Volume: 162, Issue:3 Topics: Animals; Cell Survival; Cells, Cultured; Comet Assay; DNA; DNA Damage; DNA Repair; Electrophoresis,	2006
Dual aetiologies for hyperinsulinaemic hypoglycaemia in one patient. Hong Kong medical journal = Xianggang yi xue za zhi, 2007, Volume: 13, Issue:1 Topics: Adult; Gliclazide; Humans; Hyperinsulinism; Hypoglycemia; Hypoglycemic Agents; Insulinoma; Male; Pan	2007
Insulinoma causing hypoglycemia in a patient with type 2 diabetes. Journal of the Formosan Medical Association = Taiwan yi zhi, 2007, Volume: 106, Issue:5 Topics: Aged; Diabetes Mellitus, Type 2; Female; Gliclazide; Humans; Hyperinsulinism; Hypoglycemia; Hypoglyc	2007